Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer-Reference-Cited by-同舟云学术

Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer

Published:2022-11-11 Issue:1 Volume:73 Page:8-16
ISSN:0007-9235
Container-title:CA: A Cancer Journal for Clinicians
language:en
Short-container-title:CA A Cancer J Clinicians

Author:

Cass Ilana¹^ORCID,Roberts Jill N. T.¹,Benoit Philip R.²,Jensen Nicholas V.³

Affiliation:

1. Division of Gynecologic Oncology Department of Obstetrics and Gynecology Dartmouth‐Hitchcock Medical Center Lebanon New Hampshire USA

2. Pharmacy Hematology/Oncology Norris Cotton Cancer Center Lebanon New Hampshire USA

3. Medical Genetics Norris Cotton Cancer Center Lebanon New Hampshire USA

Publisher

Wiley

Subject

Oncology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21764

Reference34 articles.

1. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper

2. Cancer Statistics, 2021

3. Inherited Mutations in Women With Ovarian Carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbamoylation at C-8 position of natural 3-arylcoumarin scaffold for the discovery of novel PARP-1 inhibitors with potent anticancer activity;European Journal of Medicinal Chemistry;2024-11

2. Design, synthesis and biological evaluation of matrine contains benzimidazole derivatives as dual TOPOI and PARP inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-04

3. Recent advances in the treatment for gynecologic oncology;Holistic Integrative Oncology;2024-01-04

4. Indirubin derivatives as bifunctional molecules inducing DNA damage and targeting PARP for the treatment of cancer;European Journal of Medicinal Chemistry;2023-12

5. Multiple drugs;Reactions Weekly;2023-04-22